Paradigm Medical Ind Stock Analysis

PDMI Stock  USD 0.0001  0.00  0.00%   
Paradigm Medical's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Paradigm Medical's financial risk is the risk to Paradigm Medical stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Paradigm Medical's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Paradigm Medical is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Paradigm Medical to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Paradigm Medical is said to be less leveraged. If creditors hold a majority of Paradigm Medical's assets, the Company is said to be highly leveraged.
Paradigm Medical Ind is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Paradigm Medical pink sheet analysis is to determine its intrinsic value, which is an estimate of what Paradigm Medical Ind is worth, separate from its market price. There are two main types of Paradigm Medical's stock analysis: fundamental analysis and technical analysis.
The Paradigm Medical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Paradigm Medical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Paradigm Medical Ind. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Paradigm Pink Sheet Analysis Notes

The company had not issued any dividends in recent years. Paradigm Medical Ind had 1:100 split on the 3rd of February 2011. Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company was founded in 1989 and is based in Salt Lake City, Utah. Paradigm Medical operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 5 people.The quote for Paradigm Medical Ind is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Paradigm Medical Ind contact the company at 801-977-8970 or learn more at https://www.paradigm-medical.com.

Paradigm Medical Ind Investment Alerts

Paradigm Medical Ind generated a negative expected return over the last 90 days
Paradigm Medical Ind has some characteristics of a very speculative penny stock
Paradigm Medical Ind currently holds 615 K in liabilities. Paradigm Medical Ind has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Paradigm Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Paradigm Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Paradigm Medical Ind sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Paradigm to invest in growth at high rates of return. When we think about Paradigm Medical's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 772 K. Net Loss for the year was (474 K) with profit before overhead, payroll, taxes, and interest of 525 K.
Paradigm Medical Ind currently holds about 21 K in cash with (74 K) of positive cash flow from operations.

Paradigm Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.5 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Paradigm Medical's market, we take the total number of its shares issued and multiply it by Paradigm Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Paradigm Profitablity

The company has Profit Margin (PM) of (0.46) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.27) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.27.

Technical Drivers

Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Paradigm Medical, as well as the relationship between them.

Paradigm Medical Ind Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Paradigm Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Paradigm Medical Ind. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Paradigm Medical Outstanding Bonds

Paradigm Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Paradigm Medical Ind uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Paradigm bonds can be classified according to their maturity, which is the date when Paradigm Medical Ind has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Paradigm Medical Ind Debt to Cash Allocation

Paradigm Medical Ind currently holds 615 K in liabilities. Paradigm Medical Ind has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Paradigm Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Paradigm Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Paradigm Medical Ind sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Paradigm to invest in growth at high rates of return. When we think about Paradigm Medical's use of debt, we should always consider it together with cash and equity.

Paradigm Medical Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Paradigm Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Paradigm Medical, which in turn will lower the firm's financial flexibility.

Paradigm Medical Corporate Bonds Issued

Most Paradigm bonds can be classified according to their maturity, which is the date when Paradigm Medical Ind has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

About Paradigm Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Paradigm Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Paradigm shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Paradigm Medical. By using and applying Paradigm Pink Sheet analysis, traders can create a robust methodology for identifying Paradigm entry and exit points for their positions.
Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company was founded in 1989 and is based in Salt Lake City, Utah. Paradigm Medical operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 5 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Paradigm Medical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

Complementary Tools for Paradigm Pink Sheet analysis

When running Paradigm Medical's price analysis, check to measure Paradigm Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Paradigm Medical is operating at the current time. Most of Paradigm Medical's value examination focuses on studying past and present price action to predict the probability of Paradigm Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Paradigm Medical's price. Additionally, you may evaluate how the addition of Paradigm Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing